nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—SIGMAR1—Donepezil—Alzheimer's disease	0.74	1	CbGbCtD
Pentazocine—OPRM1—telencephalic ventricle—Alzheimer's disease	0.00866	0.213	CbGeAlD
Pentazocine—Grand mal convulsion—Donepezil—Alzheimer's disease	0.00467	0.0281	CcSEcCtD
Pentazocine—Grand mal convulsion—Memantine—Alzheimer's disease	0.00424	0.0255	CcSEcCtD
Pentazocine—OPRD1—forebrain—Alzheimer's disease	0.00332	0.0817	CbGeAlD
Pentazocine—OPRK1—forebrain—Alzheimer's disease	0.00318	0.0783	CbGeAlD
Pentazocine—Nystagmus—Donepezil—Alzheimer's disease	0.00312	0.0187	CcSEcCtD
Pentazocine—OPRD1—telencephalon—Alzheimer's disease	0.00305	0.0751	CbGeAlD
Pentazocine—Nystagmus—Rivastigmine—Alzheimer's disease	0.00277	0.0166	CcSEcCtD
Pentazocine—Apnoea—Memantine—Alzheimer's disease	0.00238	0.0143	CcSEcCtD
Pentazocine—Apnoea—Rivastigmine—Alzheimer's disease	0.00233	0.014	CcSEcCtD
Pentazocine—OPRM1—forebrain—Alzheimer's disease	0.00226	0.0557	CbGeAlD
Pentazocine—OPRM1—telencephalon—Alzheimer's disease	0.00208	0.0512	CbGeAlD
Pentazocine—Urinary retention—Galantamine—Alzheimer's disease	0.00198	0.0119	CcSEcCtD
Pentazocine—Euphoric mood—Donepezil—Alzheimer's disease	0.00191	0.0115	CcSEcCtD
Pentazocine—OPRD1—nervous system—Alzheimer's disease	0.0018	0.0444	CbGeAlD
Pentazocine—OPRD1—central nervous system—Alzheimer's disease	0.00173	0.0427	CbGeAlD
Pentazocine—Abdominal discomfort—Galantamine—Alzheimer's disease	0.00173	0.0104	CcSEcCtD
Pentazocine—OPRK1—nervous system—Alzheimer's disease	0.00173	0.0425	CbGeAlD
Pentazocine—SIGMAR1—telencephalon—Alzheimer's disease	0.00172	0.0423	CbGeAlD
Pentazocine—Hepatic function abnormal—Memantine—Alzheimer's disease	0.00168	0.0101	CcSEcCtD
Pentazocine—OPRK1—central nervous system—Alzheimer's disease	0.00166	0.0409	CbGeAlD
Pentazocine—Disorientation—Memantine—Alzheimer's disease	0.00164	0.00985	CcSEcCtD
Pentazocine—OPRK1—cerebellum—Alzheimer's disease	0.00162	0.04	CbGeAlD
Pentazocine—Face oedema—Donepezil—Alzheimer's disease	0.00156	0.00937	CcSEcCtD
Pentazocine—Irritability—Donepezil—Alzheimer's disease	0.00154	0.00926	CcSEcCtD
Pentazocine—Urinary retention—Donepezil—Alzheimer's disease	0.00154	0.00923	CcSEcCtD
Pentazocine—Diplopia—Memantine—Alzheimer's disease	0.00147	0.00881	CcSEcCtD
Pentazocine—Cramp muscle—Donepezil—Alzheimer's disease	0.00145	0.00874	CcSEcCtD
Pentazocine—Diplopia—Rivastigmine—Alzheimer's disease	0.00143	0.00862	CcSEcCtD
Pentazocine—Hallucination—Galantamine—Alzheimer's disease	0.00143	0.00862	CcSEcCtD
Pentazocine—Irritability—Memantine—Alzheimer's disease	0.0014	0.00841	CcSEcCtD
Pentazocine—Urinary retention—Memantine—Alzheimer's disease	0.00139	0.00838	CcSEcCtD
Pentazocine—Visual impairment—Galantamine—Alzheimer's disease	0.00139	0.00835	CcSEcCtD
Pentazocine—Face oedema—Rivastigmine—Alzheimer's disease	0.00139	0.00832	CcSEcCtD
Pentazocine—Eosinophilia—Donepezil—Alzheimer's disease	0.00138	0.00831	CcSEcCtD
Pentazocine—OPRD1—brain—Alzheimer's disease	0.00138	0.0339	CbGeAlD
Pentazocine—Urinary retention—Rivastigmine—Alzheimer's disease	0.00136	0.0082	CcSEcCtD
Pentazocine—Sweating increased—Donepezil—Alzheimer's disease	0.00136	0.00817	CcSEcCtD
Pentazocine—Tinnitus—Galantamine—Alzheimer's disease	0.00134	0.00808	CcSEcCtD
Pentazocine—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00134	0.00804	CcSEcCtD
Pentazocine—Flushing—Galantamine—Alzheimer's disease	0.00134	0.00804	CcSEcCtD
Pentazocine—OPRK1—brain—Alzheimer's disease	0.00132	0.0325	CbGeAlD
Pentazocine—Cramp muscle—Rivastigmine—Alzheimer's disease	0.00129	0.00776	CcSEcCtD
Pentazocine—Sweating increased—Memantine—Alzheimer's disease	0.00123	0.00742	CcSEcCtD
Pentazocine—Dysgeusia—Galantamine—Alzheimer's disease	0.00123	0.00739	CcSEcCtD
Pentazocine—OPRM1—nervous system—Alzheimer's disease	0.00123	0.0303	CbGeAlD
Pentazocine—Sweating increased—Rivastigmine—Alzheimer's disease	0.00121	0.00726	CcSEcCtD
Pentazocine—Muscle spasms—Galantamine—Alzheimer's disease	0.00121	0.00725	CcSEcCtD
Pentazocine—Sweating—Donepezil—Alzheimer's disease	0.00119	0.00717	CcSEcCtD
Pentazocine—Vision blurred—Galantamine—Alzheimer's disease	0.00118	0.00711	CcSEcCtD
Pentazocine—OPRM1—central nervous system—Alzheimer's disease	0.00118	0.0291	CbGeAlD
Pentazocine—Tremor—Galantamine—Alzheimer's disease	0.00118	0.00707	CcSEcCtD
Pentazocine—Agitation—Galantamine—Alzheimer's disease	0.00115	0.00693	CcSEcCtD
Pentazocine—Vertigo—Galantamine—Alzheimer's disease	0.00113	0.00678	CcSEcCtD
Pentazocine—Syncope—Galantamine—Alzheimer's disease	0.00113	0.00676	CcSEcCtD
Pentazocine—Hallucination—Donepezil—Alzheimer's disease	0.00111	0.00668	CcSEcCtD
Pentazocine—Loss of consciousness—Galantamine—Alzheimer's disease	0.0011	0.00663	CcSEcCtD
Pentazocine—Hypertension—Galantamine—Alzheimer's disease	0.00108	0.00651	CcSEcCtD
Pentazocine—Visual impairment—Donepezil—Alzheimer's disease	0.00108	0.00647	CcSEcCtD
Pentazocine—Sweating—Rivastigmine—Alzheimer's disease	0.00106	0.00637	CcSEcCtD
Pentazocine—Agranulocytosis—Memantine—Alzheimer's disease	0.00105	0.00634	CcSEcCtD
Pentazocine—Dry mouth—Galantamine—Alzheimer's disease	0.00105	0.00628	CcSEcCtD
Pentazocine—Tinnitus—Donepezil—Alzheimer's disease	0.00104	0.00626	CcSEcCtD
Pentazocine—Confusional state—Galantamine—Alzheimer's disease	0.00103	0.00621	CcSEcCtD
Pentazocine—Hallucination—Memantine—Alzheimer's disease	0.00101	0.00607	CcSEcCtD
Pentazocine—Shock—Galantamine—Alzheimer's disease	0.00101	0.00606	CcSEcCtD
Pentazocine—Chills—Donepezil—Alzheimer's disease	0.001	0.00603	CcSEcCtD
Pentazocine—Tachycardia—Galantamine—Alzheimer's disease	0.001	0.00601	CcSEcCtD
Pentazocine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00099	0.00595	CcSEcCtD
Pentazocine—Hallucination—Rivastigmine—Alzheimer's disease	0.000988	0.00593	CcSEcCtD
Pentazocine—Visual impairment—Memantine—Alzheimer's disease	0.000978	0.00588	CcSEcCtD
Pentazocine—Anorexia—Galantamine—Alzheimer's disease	0.000977	0.00587	CcSEcCtD
Pentazocine—Erythema multiforme—Memantine—Alzheimer's disease	0.000959	0.00576	CcSEcCtD
Pentazocine—Hypotension—Galantamine—Alzheimer's disease	0.000957	0.00575	CcSEcCtD
Pentazocine—Visual impairment—Rivastigmine—Alzheimer's disease	0.000957	0.00575	CcSEcCtD
Pentazocine—SIGMAR1—cerebellum—Alzheimer's disease	0.000955	0.0235	CbGeAlD
Pentazocine—Dysgeusia—Donepezil—Alzheimer's disease	0.000953	0.00572	CcSEcCtD
Pentazocine—Tinnitus—Memantine—Alzheimer's disease	0.000946	0.00568	CcSEcCtD
Pentazocine—Flushing—Memantine—Alzheimer's disease	0.000942	0.00566	CcSEcCtD
Pentazocine—OPRM1—brain—Alzheimer's disease	0.000939	0.0231	CbGeAlD
Pentazocine—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000939	0.00564	CcSEcCtD
Pentazocine—Muscle spasms—Donepezil—Alzheimer's disease	0.000935	0.00562	CcSEcCtD
Pentazocine—Insomnia—Galantamine—Alzheimer's disease	0.000927	0.00557	CcSEcCtD
Pentazocine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000925	0.00556	CcSEcCtD
Pentazocine—Flushing—Rivastigmine—Alzheimer's disease	0.000921	0.00554	CcSEcCtD
Pentazocine—Paraesthesia—Galantamine—Alzheimer's disease	0.00092	0.00553	CcSEcCtD
Pentazocine—Vision blurred—Donepezil—Alzheimer's disease	0.000917	0.00551	CcSEcCtD
Pentazocine—Tremor—Donepezil—Alzheimer's disease	0.000911	0.00548	CcSEcCtD
Pentazocine—Somnolence—Galantamine—Alzheimer's disease	0.000911	0.00547	CcSEcCtD
Pentazocine—Chills—Memantine—Alzheimer's disease	0.00091	0.00547	CcSEcCtD
Pentazocine—Agitation—Donepezil—Alzheimer's disease	0.000894	0.00537	CcSEcCtD
Pentazocine—Chills—Rivastigmine—Alzheimer's disease	0.000891	0.00535	CcSEcCtD
Pentazocine—Decreased appetite—Galantamine—Alzheimer's disease	0.000891	0.00535	CcSEcCtD
Pentazocine—Constipation—Galantamine—Alzheimer's disease	0.000876	0.00526	CcSEcCtD
Pentazocine—Vertigo—Donepezil—Alzheimer's disease	0.000874	0.00525	CcSEcCtD
Pentazocine—Syncope—Donepezil—Alzheimer's disease	0.000872	0.00524	CcSEcCtD
Pentazocine—Dysgeusia—Memantine—Alzheimer's disease	0.000865	0.0052	CcSEcCtD
Pentazocine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000855	0.00514	CcSEcCtD
Pentazocine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000846	0.00508	CcSEcCtD
Pentazocine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000844	0.00507	CcSEcCtD
Pentazocine—Hypertension—Donepezil—Alzheimer's disease	0.00084	0.00505	CcSEcCtD
Pentazocine—Vision blurred—Memantine—Alzheimer's disease	0.000832	0.005	CcSEcCtD
Pentazocine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000831	0.00499	CcSEcCtD
Pentazocine—Tremor—Memantine—Alzheimer's disease	0.000828	0.00497	CcSEcCtD
Pentazocine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000814	0.00489	CcSEcCtD
Pentazocine—Agitation—Memantine—Alzheimer's disease	0.000812	0.00488	CcSEcCtD
Pentazocine—Dry mouth—Donepezil—Alzheimer's disease	0.00081	0.00487	CcSEcCtD
Pentazocine—Tremor—Rivastigmine—Alzheimer's disease	0.00081	0.00486	CcSEcCtD
Pentazocine—Confusional state—Donepezil—Alzheimer's disease	0.000801	0.00481	CcSEcCtD
Pentazocine—Agitation—Rivastigmine—Alzheimer's disease	0.000794	0.00477	CcSEcCtD
Pentazocine—Vertigo—Memantine—Alzheimer's disease	0.000794	0.00477	CcSEcCtD
Pentazocine—Syncope—Memantine—Alzheimer's disease	0.000792	0.00476	CcSEcCtD
Pentazocine—Shock—Donepezil—Alzheimer's disease	0.000781	0.00469	CcSEcCtD
Pentazocine—Vertigo—Rivastigmine—Alzheimer's disease	0.000776	0.00466	CcSEcCtD
Pentazocine—Loss of consciousness—Memantine—Alzheimer's disease	0.000776	0.00466	CcSEcCtD
Pentazocine—SIGMAR1—brain—Alzheimer's disease	0.000775	0.0191	CbGeAlD
Pentazocine—Syncope—Rivastigmine—Alzheimer's disease	0.000775	0.00466	CcSEcCtD
Pentazocine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000768	0.00461	CcSEcCtD
Pentazocine—Hypertension—Memantine—Alzheimer's disease	0.000763	0.00458	CcSEcCtD
Pentazocine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000759	0.00456	CcSEcCtD
Pentazocine—Anorexia—Donepezil—Alzheimer's disease	0.000757	0.00455	CcSEcCtD
Pentazocine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000755	0.00454	CcSEcCtD
Pentazocine—Hypertension—Rivastigmine—Alzheimer's disease	0.000746	0.00448	CcSEcCtD
Pentazocine—Hypotension—Donepezil—Alzheimer's disease	0.000742	0.00446	CcSEcCtD
Pentazocine—Dry mouth—Memantine—Alzheimer's disease	0.000735	0.00442	CcSEcCtD
Pentazocine—Asthenia—Galantamine—Alzheimer's disease	0.000735	0.00442	CcSEcCtD
Pentazocine—Confusional state—Memantine—Alzheimer's disease	0.000727	0.00437	CcSEcCtD
Pentazocine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000719	0.00432	CcSEcCtD
Pentazocine—Insomnia—Donepezil—Alzheimer's disease	0.000718	0.00431	CcSEcCtD
Pentazocine—Paraesthesia—Donepezil—Alzheimer's disease	0.000713	0.00428	CcSEcCtD
Pentazocine—Confusional state—Rivastigmine—Alzheimer's disease	0.000711	0.00427	CcSEcCtD
Pentazocine—Shock—Memantine—Alzheimer's disease	0.000709	0.00426	CcSEcCtD
Pentazocine—Dyspnoea—Donepezil—Alzheimer's disease	0.000708	0.00425	CcSEcCtD
Pentazocine—Somnolence—Donepezil—Alzheimer's disease	0.000706	0.00424	CcSEcCtD
Pentazocine—Tachycardia—Memantine—Alzheimer's disease	0.000704	0.00423	CcSEcCtD
Pentazocine—Diarrhoea—Galantamine—Alzheimer's disease	0.000701	0.00421	CcSEcCtD
Pentazocine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000697	0.00419	CcSEcCtD
Pentazocine—Shock—Rivastigmine—Alzheimer's disease	0.000694	0.00417	CcSEcCtD
Pentazocine—Decreased appetite—Donepezil—Alzheimer's disease	0.00069	0.00415	CcSEcCtD
Pentazocine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000688	0.00414	CcSEcCtD
Pentazocine—Anorexia—Memantine—Alzheimer's disease	0.000687	0.00413	CcSEcCtD
Pentazocine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000682	0.0041	CcSEcCtD
Pentazocine—Constipation—Donepezil—Alzheimer's disease	0.000679	0.00408	CcSEcCtD
Pentazocine—Dizziness—Galantamine—Alzheimer's disease	0.000677	0.00407	CcSEcCtD
Pentazocine—Hypotension—Memantine—Alzheimer's disease	0.000674	0.00405	CcSEcCtD
Pentazocine—Anorexia—Rivastigmine—Alzheimer's disease	0.000672	0.00404	CcSEcCtD
Pentazocine—Hypotension—Rivastigmine—Alzheimer's disease	0.000659	0.00396	CcSEcCtD
Pentazocine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000654	0.00393	CcSEcCtD
Pentazocine—Insomnia—Memantine—Alzheimer's disease	0.000652	0.00392	CcSEcCtD
Pentazocine—Vomiting—Galantamine—Alzheimer's disease	0.000651	0.00391	CcSEcCtD
Pentazocine—Paraesthesia—Memantine—Alzheimer's disease	0.000647	0.00389	CcSEcCtD
Pentazocine—Dermatitis—Galantamine—Alzheimer's disease	0.000645	0.00388	CcSEcCtD
Pentazocine—Dyspnoea—Memantine—Alzheimer's disease	0.000643	0.00386	CcSEcCtD
Pentazocine—Headache—Galantamine—Alzheimer's disease	0.000642	0.00386	CcSEcCtD
Pentazocine—Somnolence—Memantine—Alzheimer's disease	0.000641	0.00385	CcSEcCtD
Pentazocine—Insomnia—Rivastigmine—Alzheimer's disease	0.000638	0.00383	CcSEcCtD
Pentazocine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000633	0.00381	CcSEcCtD
Pentazocine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000629	0.00378	CcSEcCtD
Pentazocine—Somnolence—Rivastigmine—Alzheimer's disease	0.000627	0.00377	CcSEcCtD
Pentazocine—Decreased appetite—Memantine—Alzheimer's disease	0.000627	0.00377	CcSEcCtD
Pentazocine—Constipation—Memantine—Alzheimer's disease	0.000616	0.0037	CcSEcCtD
Pentazocine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000613	0.00368	CcSEcCtD
Pentazocine—Nausea—Galantamine—Alzheimer's disease	0.000609	0.00366	CcSEcCtD
Pentazocine—Constipation—Rivastigmine—Alzheimer's disease	0.000603	0.00362	CcSEcCtD
Pentazocine—Feeling abnormal—Memantine—Alzheimer's disease	0.000594	0.00357	CcSEcCtD
Pentazocine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000585	0.00351	CcSEcCtD
Pentazocine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000581	0.00349	CcSEcCtD
Pentazocine—Asthenia—Donepezil—Alzheimer's disease	0.00057	0.00342	CcSEcCtD
Pentazocine—Pruritus—Donepezil—Alzheimer's disease	0.000562	0.00338	CcSEcCtD
Pentazocine—Diarrhoea—Donepezil—Alzheimer's disease	0.000543	0.00326	CcSEcCtD
Pentazocine—Hypersensitivity—Memantine—Alzheimer's disease	0.000531	0.00319	CcSEcCtD
Pentazocine—Dizziness—Donepezil—Alzheimer's disease	0.000525	0.00315	CcSEcCtD
Pentazocine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00052	0.00312	CcSEcCtD
Pentazocine—Asthenia—Memantine—Alzheimer's disease	0.000517	0.00311	CcSEcCtD
Pentazocine—Pruritus—Memantine—Alzheimer's disease	0.00051	0.00306	CcSEcCtD
Pentazocine—Asthenia—Rivastigmine—Alzheimer's disease	0.000506	0.00304	CcSEcCtD
Pentazocine—Vomiting—Donepezil—Alzheimer's disease	0.000505	0.00303	CcSEcCtD
Pentazocine—Dermatitis—Donepezil—Alzheimer's disease	0.0005	0.00301	CcSEcCtD
Pentazocine—Pruritus—Rivastigmine—Alzheimer's disease	0.000499	0.003	CcSEcCtD
Pentazocine—Headache—Donepezil—Alzheimer's disease	0.000497	0.00299	CcSEcCtD
Pentazocine—Diarrhoea—Memantine—Alzheimer's disease	0.000493	0.00296	CcSEcCtD
Pentazocine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000483	0.0029	CcSEcCtD
Pentazocine—Dizziness—Memantine—Alzheimer's disease	0.000477	0.00286	CcSEcCtD
Pentazocine—Nausea—Donepezil—Alzheimer's disease	0.000472	0.00283	CcSEcCtD
Pentazocine—Dizziness—Rivastigmine—Alzheimer's disease	0.000466	0.0028	CcSEcCtD
Pentazocine—Vomiting—Memantine—Alzheimer's disease	0.000458	0.00275	CcSEcCtD
Pentazocine—Dermatitis—Memantine—Alzheimer's disease	0.000454	0.00273	CcSEcCtD
Pentazocine—Headache—Memantine—Alzheimer's disease	0.000452	0.00271	CcSEcCtD
Pentazocine—Vomiting—Rivastigmine—Alzheimer's disease	0.000448	0.00269	CcSEcCtD
Pentazocine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000444	0.00267	CcSEcCtD
Pentazocine—Headache—Rivastigmine—Alzheimer's disease	0.000442	0.00265	CcSEcCtD
Pentazocine—Nausea—Memantine—Alzheimer's disease	0.000428	0.00257	CcSEcCtD
Pentazocine—Nausea—Rivastigmine—Alzheimer's disease	0.000419	0.00252	CcSEcCtD
Pentazocine—OPRM1—TCR Signaling Pathway—AKT1—Alzheimer's disease	5.62e-05	0.00106	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PLCB1—Alzheimer's disease	5.48e-05	0.00103	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—NPS—Alzheimer's disease	5.48e-05	0.00103	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—NPY—Alzheimer's disease	5.44e-05	0.00102	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—SST—Alzheimer's disease	5.41e-05	0.00102	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—GAB2—Alzheimer's disease	5.41e-05	0.00102	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IAPP—Alzheimer's disease	5.41e-05	0.00102	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—APP—Alzheimer's disease	5.28e-05	0.000994	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CRH—Alzheimer's disease	5.25e-05	0.000989	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—GAB2—Alzheimer's disease	5.23e-05	0.000985	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—SST—Alzheimer's disease	5.23e-05	0.000985	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CCL2—Alzheimer's disease	5.2e-05	0.000979	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CDK5—Alzheimer's disease	5.12e-05	0.000964	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—F2—Alzheimer's disease	5.11e-05	0.000963	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PSENEN—Alzheimer's disease	5.1e-05	0.000961	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—APP—Alzheimer's disease	5.09e-05	0.00096	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—NPY—Alzheimer's disease	5.06e-05	0.000954	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	5.06e-05	0.000953	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CCR5—Alzheimer's disease	5.04e-05	0.000949	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—IAPP—Alzheimer's disease	5.03e-05	0.000948	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APH1A—Alzheimer's disease	5.03e-05	0.000948	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PPARG—Alzheimer's disease	5e-05	0.000942	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PYY—Alzheimer's disease	4.99e-05	0.00094	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PLCB1—Alzheimer's disease	4.98e-05	0.000938	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—NPS—Alzheimer's disease	4.98e-05	0.000937	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PPP3CA—Alzheimer's disease	4.95e-05	0.000933	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—HTR2A—Alzheimer's disease	4.93e-05	0.000929	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HTR6—Alzheimer's disease	4.93e-05	0.000928	CbGpPWpGaD
Pentazocine—EBP—Metabolism—INS—Alzheimer's disease	4.91e-05	0.000924	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NCSTN—Alzheimer's disease	4.9e-05	0.000923	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CRH—Alzheimer's disease	4.89e-05	0.00092	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PLCB1—Alzheimer's disease	4.81e-05	0.000905	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—LRP1—Alzheimer's disease	4.78e-05	0.0009	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—GAB2—Alzheimer's disease	4.75e-05	0.000894	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—SST—Alzheimer's disease	4.75e-05	0.000894	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GFAP—Alzheimer's disease	4.67e-05	0.000879	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GAL—Alzheimer's disease	4.67e-05	0.000879	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—NPS—Alzheimer's disease	4.63e-05	0.000872	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—APP—Alzheimer's disease	4.63e-05	0.000871	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—NPY—Alzheimer's disease	4.6e-05	0.000866	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IAPP—Alzheimer's disease	4.57e-05	0.000861	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CCL2—Alzheimer's disease	4.56e-05	0.000859	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PSENEN—Alzheimer's disease	4.47e-05	0.000843	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CRH—Alzheimer's disease	4.44e-05	0.000836	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—GAB2—Alzheimer's disease	4.42e-05	0.000832	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—SST—Alzheimer's disease	4.42e-05	0.000832	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APH1A—Alzheimer's disease	4.41e-05	0.000831	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PLCB1—Alzheimer's disease	4.37e-05	0.000822	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CDK5—Alzheimer's disease	4.33e-05	0.000815	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—F2—Alzheimer's disease	4.32e-05	0.000814	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—APP—Alzheimer's disease	4.31e-05	0.000811	CbGpPWpGaD
Pentazocine—EBP—Metabolism—NOS3—Alzheimer's disease	4.3e-05	0.00081	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NCSTN—Alzheimer's disease	4.3e-05	0.000809	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—NPS—Alzheimer's disease	4.21e-05	0.000792	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—LRP1—Alzheimer's disease	4.19e-05	0.000789	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PPP3CA—Alzheimer's disease	4.19e-05	0.000788	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR6—Alzheimer's disease	4.16e-05	0.000784	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—A2M—Alzheimer's disease	4.11e-05	0.000775	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GFAP—Alzheimer's disease	4.09e-05	0.000771	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GAL—Alzheimer's disease	4.09e-05	0.000771	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PLCB1—Alzheimer's disease	4.06e-05	0.000765	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PRKCG—Alzheimer's disease	4.05e-05	0.000764	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—GAB2—Alzheimer's disease	4.01e-05	0.000756	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—SST—Alzheimer's disease	4.01e-05	0.000756	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PSEN2—Alzheimer's disease	3.98e-05	0.00075	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PTGS2—Alzheimer's disease	3.94e-05	0.000741	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—APP—Alzheimer's disease	3.91e-05	0.000736	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CCL2—Alzheimer's disease	3.85e-05	0.000726	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CCR5—Alzheimer's disease	3.84e-05	0.000724	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PSENEN—Alzheimer's disease	3.78e-05	0.000712	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—HTR2A—Alzheimer's disease	3.76e-05	0.000708	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APH1A—Alzheimer's disease	3.73e-05	0.000702	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PLCB1—Alzheimer's disease	3.69e-05	0.000695	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PRKCG—Alzheimer's disease	3.68e-05	0.000693	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NPY—Alzheimer's disease	3.67e-05	0.00069	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IAPP—Alzheimer's disease	3.64e-05	0.000686	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NCSTN—Alzheimer's disease	3.63e-05	0.000684	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—A2M—Alzheimer's disease	3.61e-05	0.000679	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PRKCG—Alzheimer's disease	3.56e-05	0.00067	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—LRP1—Alzheimer's disease	3.54e-05	0.000667	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CRH—Alzheimer's disease	3.54e-05	0.000666	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PSEN2—Alzheimer's disease	3.49e-05	0.000658	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCR5—Alzheimer's disease	3.49e-05	0.000657	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GAL—Alzheimer's disease	3.46e-05	0.000651	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GFAP—Alzheimer's disease	3.46e-05	0.000651	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—HTR2A—Alzheimer's disease	3.41e-05	0.000643	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CCR5—Alzheimer's disease	3.37e-05	0.000635	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NPS—Alzheimer's disease	3.35e-05	0.000631	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PPP3CA—Alzheimer's disease	3.34e-05	0.000628	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—HTR2A—Alzheimer's disease	3.3e-05	0.000621	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—F2—Alzheimer's disease	3.3e-05	0.000621	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PTK2B—Alzheimer's disease	3.29e-05	0.000619	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PRKCG—Alzheimer's disease	3.23e-05	0.000608	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NPY—Alzheimer's disease	3.21e-05	0.000605	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SST—Alzheimer's disease	3.2e-05	0.000602	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NTRK2—Alzheimer's disease	3.2e-05	0.000602	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GAB2—Alzheimer's disease	3.2e-05	0.000602	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IAPP—Alzheimer's disease	3.19e-05	0.000602	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CALM1—Alzheimer's disease	3.19e-05	0.0006	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GSK3A—Alzheimer's disease	3.17e-05	0.000597	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APP—Alzheimer's disease	3.12e-05	0.000587	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CRH—Alzheimer's disease	3.1e-05	0.000584	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCR5—Alzheimer's disease	3.06e-05	0.000576	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—A2M—Alzheimer's disease	3.05e-05	0.000574	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PRKCG—Alzheimer's disease	3e-05	0.000566	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HTR2A—Alzheimer's disease	2.99e-05	0.000564	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—F2—Alzheimer's disease	2.99e-05	0.000564	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PSEN2—Alzheimer's disease	2.95e-05	0.000556	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PLCB1—Alzheimer's disease	2.94e-05	0.000554	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NPS—Alzheimer's disease	2.94e-05	0.000554	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PPP3CA—Alzheimer's disease	2.93e-05	0.000551	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—F2—Alzheimer's disease	2.89e-05	0.000544	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PTK2B—Alzheimer's disease	2.88e-05	0.000543	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CCR5—Alzheimer's disease	2.85e-05	0.000536	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SST—Alzheimer's disease	2.8e-05	0.000528	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NTRK2—Alzheimer's disease	2.8e-05	0.000528	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GAB2—Alzheimer's disease	2.8e-05	0.000528	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CALM1—Alzheimer's disease	2.79e-05	0.000526	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—HTR2A—Alzheimer's disease	2.79e-05	0.000525	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GSK3A—Alzheimer's disease	2.78e-05	0.000524	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NGFR—Alzheimer's disease	2.74e-05	0.000517	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APP—Alzheimer's disease	2.73e-05	0.000515	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PRKCG—Alzheimer's disease	2.73e-05	0.000514	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CREB1—Alzheimer's disease	2.73e-05	0.000514	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NPY—Alzheimer's disease	2.72e-05	0.000512	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IAPP—Alzheimer's disease	2.7e-05	0.000509	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ADAM10—Alzheimer's disease	2.68e-05	0.000505	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCL2—Alzheimer's disease	2.67e-05	0.000503	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—F2—Alzheimer's disease	2.62e-05	0.000494	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CRH—Alzheimer's disease	2.62e-05	0.000494	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCR5—Alzheimer's disease	2.59e-05	0.000487	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PLCB1—Alzheimer's disease	2.58e-05	0.000486	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—S100B—Alzheimer's disease	2.53e-05	0.000477	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	2.53e-05	0.000477	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NPS—Alzheimer's disease	2.48e-05	0.000468	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	2.47e-05	0.000466	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—F2—Alzheimer's disease	2.44e-05	0.00046	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTK2B—Alzheimer's disease	2.44e-05	0.000459	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IGF2—Alzheimer's disease	2.41e-05	0.000455	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NGFR—Alzheimer's disease	2.41e-05	0.000453	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CREB1—Alzheimer's disease	2.39e-05	0.00045	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NTRK2—Alzheimer's disease	2.37e-05	0.000446	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GAB2—Alzheimer's disease	2.37e-05	0.000446	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SST—Alzheimer's disease	2.37e-05	0.000446	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CALM1—Alzheimer's disease	2.36e-05	0.000445	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ADAM10—Alzheimer's disease	2.35e-05	0.000443	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GSK3A—Alzheimer's disease	2.35e-05	0.000443	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCL2—Alzheimer's disease	2.34e-05	0.000441	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IGF1R—Alzheimer's disease	2.33e-05	0.000439	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APP—Alzheimer's disease	2.31e-05	0.000435	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—LPL—Alzheimer's disease	2.24e-05	0.000421	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—S100B—Alzheimer's disease	2.22e-05	0.000419	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—F2—Alzheimer's disease	2.22e-05	0.000418	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MEF2C—Alzheimer's disease	2.22e-05	0.000418	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PLCB1—Alzheimer's disease	2.18e-05	0.000411	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PRKCG—Alzheimer's disease	2.17e-05	0.00041	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NGF—Alzheimer's disease	2.12e-05	0.000399	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IGF2—Alzheimer's disease	2.12e-05	0.000399	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCR5—Alzheimer's disease	2.06e-05	0.000388	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IGF1R—Alzheimer's disease	2.05e-05	0.000385	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NGFR—Alzheimer's disease	2.03e-05	0.000383	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CREB1—Alzheimer's disease	2.02e-05	0.000381	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HTR2A—Alzheimer's disease	2.02e-05	0.00038	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADAM10—Alzheimer's disease	1.99e-05	0.000374	CbGpPWpGaD
Pentazocine—EBP—Metabolism—AKT1—Alzheimer's disease	1.98e-05	0.000373	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCL2—Alzheimer's disease	1.98e-05	0.000372	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—LPL—Alzheimer's disease	1.96e-05	0.000369	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MEF2C—Alzheimer's disease	1.94e-05	0.000366	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRKCG—Alzheimer's disease	1.91e-05	0.000359	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CALM1—Alzheimer's disease	1.88e-05	0.000354	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—S100B—Alzheimer's disease	1.88e-05	0.000354	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APOE—Alzheimer's disease	1.88e-05	0.000353	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—LEP—Alzheimer's disease	1.88e-05	0.000353	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NGF—Alzheimer's disease	1.86e-05	0.00035	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CAV1—Alzheimer's disease	1.86e-05	0.00035	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCR5—Alzheimer's disease	1.81e-05	0.00034	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ESR1—Alzheimer's disease	1.79e-05	0.000337	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IGF2—Alzheimer's disease	1.79e-05	0.000337	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HTR2A—Alzheimer's disease	1.77e-05	0.000333	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—F2—Alzheimer's disease	1.77e-05	0.000333	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.73e-05	0.000326	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IGF1R—Alzheimer's disease	1.73e-05	0.000326	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—LPL—Alzheimer's disease	1.66e-05	0.000312	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CALM1—Alzheimer's disease	1.65e-05	0.000311	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—LEP—Alzheimer's disease	1.64e-05	0.00031	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOE—Alzheimer's disease	1.64e-05	0.00031	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MEF2C—Alzheimer's disease	1.64e-05	0.000309	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CAV1—Alzheimer's disease	1.63e-05	0.000307	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GSK3B—Alzheimer's disease	1.62e-05	0.000306	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKCG—Alzheimer's disease	1.61e-05	0.000304	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CREB1—Alzheimer's disease	1.61e-05	0.000303	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—INS—Alzheimer's disease	1.6e-05	0.000302	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL2—Alzheimer's disease	1.58e-05	0.000297	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NGF—Alzheimer's disease	1.57e-05	0.000296	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ESR1—Alzheimer's disease	1.57e-05	0.000296	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—F2—Alzheimer's disease	1.55e-05	0.000292	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IGF1—Alzheimer's disease	1.55e-05	0.000292	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCR5—Alzheimer's disease	1.53e-05	0.000288	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.52e-05	0.000286	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR2A—Alzheimer's disease	1.49e-05	0.000282	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GSK3B—Alzheimer's disease	1.42e-05	0.000268	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CREB1—Alzheimer's disease	1.41e-05	0.000266	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NOS3—Alzheimer's disease	1.4e-05	0.000265	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—INS—Alzheimer's disease	1.4e-05	0.000265	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CALM1—Alzheimer's disease	1.39e-05	0.000263	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—LEP—Alzheimer's disease	1.39e-05	0.000262	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOE—Alzheimer's disease	1.39e-05	0.000262	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL2—Alzheimer's disease	1.38e-05	0.00026	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CAV1—Alzheimer's disease	1.38e-05	0.000259	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IGF1—Alzheimer's disease	1.36e-05	0.000256	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ESR1—Alzheimer's disease	1.33e-05	0.00025	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—F2—Alzheimer's disease	1.31e-05	0.000247	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.28e-05	0.000242	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NOS3—Alzheimer's disease	1.23e-05	0.000232	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.2e-05	0.000227	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GSK3B—Alzheimer's disease	1.2e-05	0.000227	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CREB1—Alzheimer's disease	1.19e-05	0.000225	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CASP3—Alzheimer's disease	1.19e-05	0.000225	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—INS—Alzheimer's disease	1.19e-05	0.000224	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL6—Alzheimer's disease	1.18e-05	0.000223	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL2—Alzheimer's disease	1.17e-05	0.00022	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IGF1—Alzheimer's disease	1.15e-05	0.000216	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAPK8—Alzheimer's disease	1.1e-05	0.000206	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AKT1—Alzheimer's disease	1.09e-05	0.000206	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.06e-05	0.000199	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CASP3—Alzheimer's disease	1.05e-05	0.000197	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NOS3—Alzheimer's disease	1.04e-05	0.000196	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6—Alzheimer's disease	1.04e-05	0.000196	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—VEGFA—Alzheimer's disease	1.01e-05	0.000191	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAPK8—Alzheimer's disease	9.61e-06	0.000181	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AKT1—Alzheimer's disease	9.58e-06	0.000181	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TGFB1—Alzheimer's disease	9.29e-06	0.000175	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	8.92e-06	0.000168	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—VEGFA—Alzheimer's disease	8.87e-06	0.000167	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CASP3—Alzheimer's disease	8.84e-06	0.000166	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6—Alzheimer's disease	8.78e-06	0.000165	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TGFB1—Alzheimer's disease	8.14e-06	0.000153	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAPK8—Alzheimer's disease	8.12e-06	0.000153	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AKT1—Alzheimer's disease	8.1e-06	0.000153	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TP53—Alzheimer's disease	7.65e-06	0.000144	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—VEGFA—Alzheimer's disease	7.5e-06	0.000141	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6—Alzheimer's disease	7e-06	0.000132	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TGFB1—Alzheimer's disease	6.88e-06	0.00013	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TP53—Alzheimer's disease	6.71e-06	0.000126	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AKT1—Alzheimer's disease	6.46e-06	0.000122	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6—Alzheimer's disease	6.14e-06	0.000116	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TP53—Alzheimer's disease	5.67e-06	0.000107	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AKT1—Alzheimer's disease	5.66e-06	0.000107	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6—Alzheimer's disease	5.19e-06	9.77e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKT1—Alzheimer's disease	4.79e-06	9.01e-05	CbGpPWpGaD
